The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation ...
Indivior said the U.S. Food and Drug Administration approved label changes for its opioid-dependence treatment Sublocade, including a rapid initiation protocol and alternative injection sites.
A new study has revealed that patients who develop hyponatremia soon after starting thiazide diuretics face a higher risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback